Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

6.200.00 0.00%
The 5 analysts offering 1 year price forecasts for LXRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to LXRX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

LXRX EPS for the last quarter is −0.20 USD despite the estimation of −0.18 USD. In the next quarter EPS is expected to reach −0.18 USD. Track more of Lexicon Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Lexicon Pharmaceuticals, Inc. revenue is expected to reach ‪3.44 M‬ USD. Check out Lexicon Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, LXRX price target is 6.20 USD with a max estimate of 10.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch Lexicon Pharmaceuticals, Inc. stock price chart and keep track of the current situation with LXRX news and stock market news.
We've gathered opinions of 6 analysts rating LXRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.